Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact on daptomycin resistance using combination of daptomycin plus ceftaroline in daptomycin-susceptible and -resistant <i>Staphylococcus aureus</i>.

FEMS microbes·2026
Same author

Elevated urinary glycosaminoglycans in <i>Staphylococcus aureus</i> bacteraemia with endovascular source.

Journal of medical microbiology·2026
Same author

Pharmacokinetics of Dalbavancin in Complicated Staphylococcus aureus Bacteremia: A Secondary Analysis of the DOTS Randomized Clinical Trial.

JAMA network open·2026
Same author

Overcoming Ceftaroline Resistance in MRSA Using Ceftaroline-Carbapenem Combination Therapy.

Open forum infectious diseases·2026
Same author

Bridging specialties: repurposing platelet drugs prescribed by cardiologists to help infectious disease doctors treat <i>Staphylococcus aureus</i> bacteremia.

Platelets·2026
Same author

How health systems build capacity for antimicrobial stewardship: eight pillars to success.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2025
Same journal

Safety Profiles of Seasonal Influenza Vaccines in Chinese Children and Adolescents: A Pooled Analysis of Five Clinical Studies.

Infectious diseases and therapy·2026
Same journal

Descending Necrotizing Mediastinitis Across Age and Host-Status Groups: Diagnosis, Treatment Phases, and Outcomes in the Literature, with an Illustrative Case.

Infectious diseases and therapy·2026
Same journal

Burden of Respiratory Syncytial Virus Infection in Immunocompromised Adults: A Systematic Review of the Evidence From High-Income Countries.

Infectious diseases and therapy·2026
Same journal

Diagnostic Performance and Cost-Effectiveness of BALF mNGS in Older Adults with Pulmonary Infections.

Infectious diseases and therapy·2026
Same journal

Cost-Effectiveness of Routine Infant Meningococcal B Vaccination in the Netherlands.

Infectious diseases and therapy·2026
Same journal

Clinical and Economic Inpatient Burden of Influenza and Influenza-Like Illness in Germany 2019-2025: Analysis of Nationwide Hospital Data.

Infectious diseases and therapy·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Ceftaroline for Methicillin-Resistant Staphylococcus aureus Endovascular Infection.

Reese A Cosimi1, Kelsey Peña2, John L Lock3

  • 1Department of Infectious Diseases, Ascension, St. Louis, MO, USA. reese.cosimi@gmail.com.

Infectious Diseases and Therapy
|May 20, 2026
PubMed
Summary
This summary is machine-generated.

Ceftaroline shows promise as an alternative treatment for Methicillin-resistant Staphylococcus aureus (MRSA) endovascular infections, demonstrating comparable efficacy to vancomycin and daptomycin. Combination therapy with ceftaroline offers a viable option for high-risk patients.

Keywords:
BacteremiaCeftarolineEndovascular infectionsInfective endocarditisMethicillin-resistant Staphylococcus aureus

More Related Videos

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Related Experiment Videos

Last Updated: May 21, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Clinical Medicine

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) endovascular infections present significant mortality risks.
  • First-line vancomycin use is increasingly associated with clinical failures and toxicity, necessitating alternative treatments.
  • Ceftaroline, a beta-lactam antibiotic, exhibits anti-MRSA activity, making it a potential therapeutic option.

Purpose of the Study:

  • To review the efficacy and tolerability of ceftaroline for off-label treatment of MRSA endovascular infections.
  • To analyze studies published between 2017 and 2025 evaluating ceftaroline's role in managing these serious infections.

Main Methods:

  • A narrative review of scientific literature from 2017 to 2025.
  • Inclusion of diverse study types: 1 randomized controlled trial, 17 retrospective cohort studies, 4 case series, and 1 meta-analysis.
  • Analysis focused on treatment outcomes, failure rates, and adverse events associated with ceftaroline.

Main Results:

  • Monotherapy with ceftaroline demonstrated failure rates comparable to vancomycin and daptomycin.
  • Combination therapy involving ceftaroline with vancomycin or daptomycin showed efficacy and tolerability in high-risk MRSA bacteremia cases.
  • Ceftaroline emerged as a potential strategy for severe MRSA endovascular infections.

Conclusions:

  • Current evidence suggests ceftaroline is a valuable antibiotic option for MRSA endovascular infections, particularly in combination therapy.
  • While ceftaroline is not yet a mainstay treatment, it represents a significant therapeutic alternative for complex cases.
  • Further high-level evidence is required to solidify ceftaroline's role in the standard treatment guidelines for MRSA endovascular infections.